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The ability of a T cell receptor (TCR) to directly recognize foreign (allogeneic)-major histo-
compatibility complex (MHC) molecules underlies T cell-mediated rejection in patients 
receiving allogeneic organ transplants. In this issue, Colf et al. (2007) reveal that instead 
of mimicking the interactions formed with a self MHC, a single TCR adopts a completely 
different strategy to recognize a foreign MHC.Central to the adaptive immune 
response is the interaction between 
a T cell receptor (TCR) and pep-
tide-loaded major histocompatibility 
complex molecules (pMHC). This is a 
complicated interaction because the 
TCR corecognizes peptide antigen 
and MHC. Therefore, TCR specificity 
must accommodate the highly poly-
morphic nature of the MHC, an impor-
tant feature that enables the MHC 
molecule to bind to an enormously 
variable set of microbial antigens. 
This leads to a vast T cell repertoire 
of clonally distributed TCRs (Rudolph 
et al., 2006) in order to cope with this 
pMHC variability. Despite this recep-
tor-ligand diversity, T cell responses 
are genetically restricted to recog-
nizing host MHC molecules (MHC 
restriction) while simultaneously 
retaining antigen specificity.
During thymic T cell development, 
TCRs destined to be useful to the host 
are selected for weak reactivity with 
one or more self peptides in complex 
with self MHC; subsequently, these 
TCRs can potentially crossreact with 
microbial peptides complexed to self 
MHC. TCR crossreactivity is an impor-
tant feature of our immune system but 
can be a double-edged sword, as the 
rule of MHC restriction is violated when 
T cells are exposed to foreign (alloge-
neic)-pMHC complexes. In the case 
of organ transplantation, up to 10% of 
naive T cells react strongly to allogeneic 
pMHC, leading to allograft rejection and graft-versus-host disease. In this issue 
of Cell, Garcia and colleagues (Colf et 
al., 2007) take a step toward solving the 
riddle of the molecular basis of T cell 
alloreactivity, which has puzzled immu-
nologists for decades (Sherman and 
Chattopadhyay, 1993). Using elegant 
protein engineering, they compared 
crystal structures of a mouse TCR, 2C, 
in a complex either with its positively 
selecting ligand (self), H2Kb-dEV8, or 
with its known allogeneic (foreign) lig-
and, H2Ld-QL9.
Although at first glance, the self 
and foreign ligands appear similar, 
they possess potentially important 
Figure 1. How a T Cell Receptor Recognizes Self- Versus Foreign-pMHC Complexes
(Left) The interaction between a T cell receptor (TCR) with a self-pMHC complex is depicted. 
(Middle) Allorecognition involving mimicry by foreign pMHC may be more common between 
closely related MHC allotypes where the TCR can form interactions using a shared landscape. 
In this example, the allogeneic polymorphism (bullet) is located in the Ag-binding cleft and alters 
peptide repertoire and/or conformation. Peptide residues might also contribute to mimicry (not 
shown). 
(Right) Allorecognition that does not depend upon mimicry forms an interaction that is dis-
tinct from a cognate interaction. This interaction involves distinct self- and foreign-MHC 
residues that are not necessarily different between self- and foreign-MHC allotypes. APC, 
antigen-presenting cell.Cell 129, April 6, 2007 ©2007 Elsevier Inc. 19
differences. H2Kb and H2Ld dif-
fer by 31 amino acids, and there is 
no sequence similarity between the 
H2Kb-restricted octamer self pep-
tide, dEV8 and the H2Ld-restricted 
nonamer allopeptide, QL9. How does 
a TCR interact with two ligands that 
contain many similarities as well as 
numerous differences? Historically, 
there are two main theories that 
explain the high frequency of allore-
active T cells. The first can be inter-
preted as a “peptide-centric” hypoth-
esis that implies the TCR interacts 
with a set of amino acids shared by 
self- and allogeneic-MHC molecules, 
so the crossreaction depends cru-
cially on the peptide antigen (Matz-
inger and Bevan, 1977). The second 
theory suggests that alloreactive T 
cells might focus on polymorphic 
residues exposed on the allogeneic-
MHC molecule itself, leading to an 
“MHC-centric” TCR focus where the 
peptide is largely irrelevant (Bevan, 
1984). Colf et al. (2007) first observed 
that the TCR-self ligand interaction 
and the TCR-foreign ligand were typi-
cal of known TCR-pMHC-I structures 
but differed from each other in terms 
of docking geometry, shape comple-
mentarity, and chemistry. In the self 
complex, both the α and β chain of 
2C TCR made a roughly equal number 
of contacts with the helices of the 
MHC and the peptide. In contrast, in 
the foreign complex, each chain of 
the TCR focused on one MHC helix, 
and the interactions with the peptide 
were dominated by the β chain. Even 
the energetics of 2C binding differed 
between the complexes, with favored 
entropy in H2Ld-QL9 ligation versus 
an entropic penalty for binding H2Kb-
dEV8. However, this distinction may 
not be applicable generally, as an 
entropy-driven TCR-pMHC interac-
tion has also been observed in MHC-
restricted cognate recognition (Ely et 
al., 2006). Plasticity in the interaction 
between TCRs and pMHCs is impor-
tant for crossreactivity (Kjer-Nielsen 
et al., 2003; Rudolph et al., 2006) and 
is predicted to be involved in medi-
ating alloreactivity. Surprisingly, this 
was not the case, as the TCR actually 
adopted very similar conformations in 
the two structures.20 Cell 129, April 6, 2007 ©2007 ElsevierMost surprising, however, was the 
small number of shared contacts 
between the two structures, implying a 
limited role for mimicry between cog-
nate and allogeneic pMHC. Thus, of 
16 H2Kb contact residues conserved 
in H2Ld, only 6 were contacted by 2C 
in both complexes, and only 4 of these 
used the same residues on 2C. This 
observation is consistent with the idea 
that a small subset of largely conserved 
MHC residues provides flexible docking 
arrangements for all TCRs (Rudolph et 
al., 2006; Tynan et al., 2005). This sug-
gested that 2C alloreactivity could be 
peptide centric. Colf et al. (2007) then 
examined a high-affinity variant of 2C 
TCR, which prompted them to propose 
a tail-wagging hypothesis (referring to 
man’s best friend). This high-affinity 
variant (mutated in the CDR3α loop) 
of the 2C TCR adopted the same allo-
footprint as the wild-type allocomplex, 
which is consistent with interactions 
between the MHC (the dog) and the 
CDR1 and CDR2 loops of the TCR, and 
not the peptide (the tail), dictating the 
energetics of this interaction. Accord-
ingly, Colf et al. (2007) conclude that 
direct T cell allorecognition by the 2C 
TCR is a synthesis of both peptide-
centric and MHC-centric interactions, 
but with a heavy bias toward the MHC.
How general is this model of direct 
T cell allorecognition? Given that some 
alloreactive TCRs rely more heavily on 
the CDR3 loops (Kjer-Nielsen et al., 
2003, Borg et al., 2005) than observed 
for 2C, there are likely to be exceptions 
to this view. In addition, the nature and 
location of the polymorphisms between 
cognate- and allogeneic-MHC allo-
types will surely affect TCR focus. The 
potential role of molecular mimicry and 
the relative importance of peptide-cen-
tric versus MHC-centric bias in T cell 
allorecognition are depicted in Figure 1. 
Thus, in closely related MHC allotypes 
that differ by as little as one amino acid 
(e.g., H2Kb mutants in mice; HLA-A2, 
B44, and B27 families in humans), MHC 
mimicry is likely a key component of T 
cell allorecognition whereas specificity 
is likely to be peptide centric. This is 
consistent with the published structure 
of 2C bound to the allogeneic H2Kbm3-
dEV8 complex (Rudolph et al., 2006). 
Similarly, HLA-B*4402 and B*4403  Inc.allotypes that differ by only a single 
buried polymorphic amino acid stimu-
late strong mutual allogeneic T cell 
responses (Macdonald et al., 2003). 
Indeed, the unexpected potency of 
T cell alloresponses between closely 
related MHC allotypes probably occurs 
because positive selection of host T 
cells is purposely designed to cre-
ate a repertoire responsive to subtle 
changes in peptide display. Therefore, 
closely related MHC allotypes, with 
differences in both peptide repertoire 
and pMHC conformation of a shared 
repertoire, play straight into the thymic 
gameplan designed to generate T cell 
recognition of foreign antigens.
We can expect a fuller under-
standing of the structural basis of T 
cell allorecognition with more paired 
TCR structures in complex with their 
cognate- and allogeneic-pMHC lig-
ands. In the meantime, if imitation 
is flattery, Colf and colleagues have 
revealed that being different can also 
be notable.
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